Bruce K. Dallas

Davis Polk advised the joint bookrunning managers and representatives of the several underwriters in connection with a $317.4 million public offering of common stock by Kodiak Sciences Inc…

Davis Polk advised the joint lead book-running managers and representatives of the several underwriters in connection with a $110.5 million SEC-registered common stock offering by…

Davis Polk advised Comcast Corporation on its $4.75 billion SEC-registered debt offering of 2.650% notes due 2030, 3.250% notes due 2039 and 3.450% notes due 2050.  Comcast is a global…

Davis Polk advised the underwriters in connection with a $38.4 million initial public offering of common stock of RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on…

Davis Polk advised the underwriters in connection with the $439 million SEC-registered offering of common stock of Grocery Outlet Holding Corp. by certain existing stockholders of Grocery…

Davis Polk advised the underwriters in connection with a $202.5 million public offering of common stock by Turning Point Therapeutics, Inc. Turning Point Therapeutics’ common stock is…

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $750 million aggregate principal amount of 2.250% notes due 2029. Texas Instruments is a global…

Davis Polk advised the joint book-running managers and the lead manager in connection with a $258.8 million public offering of common stock by Portola Pharmaceuticals, Inc. The common stock…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $150 million SEC-registered common stock and pre-funded warrants…

Davis Polk advised the representatives of the several underwriters in connection with the $125 million initial public offering of common stock by Atreca, Inc. The common stock is listed on…